Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 256 | $189,929,373 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 2 | 295.84 | 592 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 4 | 291.01 | 1,164 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 10 | 315.68 | 3,157 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 11 | 300.79 | 3,309 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 12 | 300.39 | 3,605 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 12 | 314.43 | 3,773 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 16 | 301.13 | 4,818 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 20 | 289.29 | 5,786 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 20 | 296.48 | 5,930 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 21 | 291.01 | 6,111 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 24 | 288.31 | 6,919 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 22 | 317.77 | 6,991 | D |
17 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2023 | Sale | 19 | 369.92 | 7,028 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 27 | 293.61 | 7,927 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 30 | 289.44 | 8,683 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 31 | 318.68 | 9,879 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 36 | 291.01 | 10,476 | D |
17 Nov 2022 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2022 | Sale | 34 | 308.61 | 10,493 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 39 | 311.17 | 12,136 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 42 | 289.63 | 12,164 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 43 | 297.98 | 12,813 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 38 | 340.19 | 12,927 | D |
17 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 15 Nov 2023 | Sale | 35 | 369.92 | 12,947 | D |
17 May 2024 16:27 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 15 May 2024 | Sale | 32 | 430.93 | 13,790 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 51 | 288.33 | 14,705 | D |
04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2023 | Sale | 42 | 351.65 | 14,769 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 51 | 300.58 | 15,330 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 56 | 310.1 | 17,366 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 62 | 296.77 | 18,400 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 64 | 299.88 | 19,192 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 71 | 295.89 | 21,008 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 70 | 302 | 21,140 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 62 | 345.93 | 21,448 | D |
11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 09 Aug 2023 | Sale | 63 | 345.51 | 21,767 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 63 | 351.2 | 22,126 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 78 | 298.11 | 23,253 | D |
17 May 2024 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Chief Scientific Officer | 15 May 2024 | Sale | 54 | 430.93 | 23,270 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 81 | 313.37 | 25,383 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 83 | 306.57 | 25,445 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 80 | 323.33 | 25,866 | D |
01 Jun 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 30 May 2023 | Sale | 82 | 329.82 | 27,045 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 90 | 316.76 | 28,508 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 94 | 315.66 | 29,672 | D |
17 May 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 May 2024 | Sale | 69 | 430.93 | 29,734 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 102 | 294.94 | 30,084 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 100 | 303.64 | 30,364 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 96 | 317.65 | 30,494 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 100 | 312.4 | 31,240 | D |
14 Feb 2023 17:08 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 13 Feb 2023 | Sale | 113 | 300.39 | 33,944 | D |
02 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 31 Jan 2023 | Sale | 106 | 325 | 34,450 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 120 | 298.98 | 35,878 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 124 | 294.77 | 36,551 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 129 | 291.84 | 37,647 | D |
15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 100 | 400.19 | 40,019 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 135 | 299.6 | 40,446 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 120 | 348.16 | 41,779 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 299.72 | 41,961 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 145 | 292.85 | 42,463 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 305.39 | 42,755 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 153 | 309.06 | 47,286 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 183 | 288.68 | 52,828 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 185 | 292.68 | 54,146 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 163 | 349.82 | 57,021 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 189 | 301.99 | 57,076 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 200 | 296.31 | 59,262 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 172 | 346.69 | 59,631 | D |
04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2023 | Sale | 169 | 353.24 | 59,698 | D |
09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 05 May 2023 | Sale | 171 | 350.3 | 59,901 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 207 | 293.83 | 60,823 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 210 | 300.96 | 63,202 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 211 | 314.22 | 66,300 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 296.3 | 71,112 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 299.58 | 71,899 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 261 | 303.21 | 79,138 | D |
20 Mar 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 Mar 2023 | Sale | 264 | 301.07 | 79,482 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 283 | 287.2 | 81,278 | D |
11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 09 Aug 2023 | Sale | 242 | 345.51 | 83,613 | D |
16 Feb 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 14 Feb 2023 | Sale | 279 | 301.11 | 84,010 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 280 | 304.58 | 85,282 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 292 | 295.89 | 86,400 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 300 | 288.74 | 86,622 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 288 | 301.84 | 86,930 | D |
11 Oct 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 06 Oct 2023 | Sale | 242 | 360 | 87,120 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 302 | 289.6 | 87,459 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 300 | 292.86 | 87,858 | D |
19 Oct 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 17 Oct 2023 | Sale | 243 | 375 | 91,125 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 308 | 301.02 | 92,714 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 327 | 288.91 | 94,474 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 302 | 315.42 | 95,257 | D |
01 Jun 2023 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 30 May 2023 | Sale | 289 | 329.82 | 95,318 | D |
03 Apr 2024 16:02 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 02 Apr 2024 | Sale | 240 | 419 | 100,560 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 361 | 286.64 | 103,477 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 324 | 321.84 | 104,276 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 300 | 353.18 | 105,954 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 294.52 | 106,027 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 349 | 305.08 | 106,473 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 298.09 | 107,312 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 400 | 287.59 | 115,036 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)